Valančiūtė Asta, Mathieson Layla, O'Connor Richard A, Scott Jamie I, Vendrell Marc, Dorward David A, Akram Ahsan R, Dhaliwal Kevin
Translational Healthcare Technologies Group, Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ, UK.
Department of Pathology, Royal Infirmary of Edinburgh, Edinburgh EH16 4SA, UK.
Cancers (Basel). 2022 Aug 25;14(17):4119. doi: 10.3390/cancers14174119.
Augmenting T cell mediated tumor killing via immunogenic cancer cell death (ICD) is the cornerstone of emerging immunotherapeutic approaches. We investigated the potential of methylene blue photodynamic therapy (MB-PDT) to induce ICD in human lung cancer. Non-Small Cell Lung Cancer (NSCLC) cell lines and primary human lung cancer organoids were evaluated in co-culture killing assays with MB-PDT and light emitting diodes (LEDs). ICD was characterised using immunoblotting, immunofluorescence, flow cytometry and confocal microscopy. Phototherapy with MB treatment and low energy LEDs decreased the proliferation of NSCLC cell lines inducing early necrosis associated with reduced expression of the anti-apoptotic protein, Bcl2 and increased expression of ICD markers, calreticulin (CRT), intercellular cell-adhesion molecule-1 (ICAM-1) and major histocompatibility complex I (MHC-I) in NSCLC cells. MB-PDT also potentiated CD8 T cell-mediated cytolysis of lung cancer via granzyme B in lung cancer cells and primary human lung cancer organoids.
通过免疫原性癌细胞死亡(ICD)增强T细胞介导的肿瘤杀伤作用是新兴免疫治疗方法的基石。我们研究了亚甲蓝光动力疗法(MB-PDT)诱导人肺癌发生ICD的潜力。在与MB-PDT和发光二极管(LED)的共培养杀伤试验中评估了非小细胞肺癌(NSCLC)细胞系和原发性人肺癌类器官。使用免疫印迹、免疫荧光、流式细胞术和共聚焦显微镜对ICD进行表征。MB处理和低能量LED的光疗降低了NSCLC细胞系的增殖,诱导早期坏死,这与抗凋亡蛋白Bcl2表达降低以及NSCLC细胞中ICD标志物钙网蛋白(CRT)、细胞间细胞粘附分子-1(ICAM-1)和主要组织相容性复合体I(MHC-I)表达增加有关。MB-PDT还通过肺癌细胞和原发性人肺癌类器官中的颗粒酶B增强了CD8 T细胞介导的肺癌细胞溶解作用。